DOCSLIB.ORG

Rapidly Progressive and Fatal EBV-Related Encephalitis in a Patient with Advanced HIV-1 Infection at Presentation: a Case Report and Review of the Literature

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Rapidly Progressive and Fatal EBV-Related Encephalitis in a Patient with Advanced HIV-1 Infection at Presentation: a Case Report and Review of the Literature NEW MICROBIOLOGICA , 33 , 275-280, 2010 Rapidly progressive and fatal EBV-related encephalitis in a patient with advanced HIV-1 infection at presentation: a case report and review of the literature Ennio Polilli 2, Federica Sozio 1, Elena Mazzotta 1, Augusta Consorte 1, Francesco Di Masi 1, Adriana Agostinone 1, Monica Tontodonati 1, Luana Cosentino 2, Giustino Parruti 1 1Infectious Disease Unit, “Spirito Santo” Hospital, Pescara, Italy; 2Clinical Pathology Unit, “Spirito Santo” Hospital, Pescara, Italy SUMMARY Epstein-Barr virus (EBV) has been associated with primary central nervous system lymphoma and other EBV-relat - ed malignancies in HIV infected patients, and detection of EBV DNA in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) has been demonstrated to be a good marker of PCNSL. Conversely, EBV has been rarely associated with encephalitis in HIV patients. Here we describe for the first time the case of an HIV-infected, late presenter Caucasian man, diagnosed with a rapidly progressive diffuse encephalitis at presentation. A very high viral load for EBV was detected in CSF by PCR. The patient died 12 days after the onset of encephalitis in spite of supportive, an - tiviral and antiretroviral therapy. Our experience would suggest that in profoundly immunosuppressed HIV patients EBV may cause severe encephalitis in the absence of lymphoproliferative disorders. KEY WORDS: HIV, Late-presenter, EBV, Encephalitis Received December 23, 2009 Accepted February 03, 2010 INTRODUCTION have been described as related to Epstein-Barr virus (EBV), human herpes virus 6 (HHV-6) and Human immunodeficiency virus (HIV) infected mixed herpes virus infections (Martínez et al ., individuals are known to be at higher risk of de - 2007). veloping severe central nervous system (CNS) in - EBV is a B-lymphotropic virus that was initially fections caused by herpes viruses as well as her - associated with a variety of lymphoid malig - pes virus-related malignancies, although a more nances in immune-compromised patients, as favorable course of such conditions has been Burkitt’s lymphoma, Hogkin’s disease, B-cell lym - more recently reported for patients treated with phoma, primary central nervous system lym - highly active antiretroviral therapy (HAART) phoma (PCNSL), as well as with CNS infections (Kennedy et al ., 2005; Martínez et al ., 2007; as encephalitis, meningo-encephalitis and Serraino et al ., 2005). Guillain-Barré syndrome (Serraino et al ., 2005; In HIV patients, cytomegalovirus (CMV) is the Domachowske et al ., 1996; Takahashi et al ., 2005; most frequently identified cause of CNS infec - Kleinschmidt-DeMasters et al ., 2008). tions among herpes viruses, while fewer cases Detection of EBV DNA in cerebrospinal fluid (CSF) by polymerase chain reaction (PCR) has been demonstrated to be a good marker of PC - Corresponding author NSL in HIV patients in several studies Giustino Parruti, MD, PhD (Bossolasco et al ., 2002; De Luca et al ., 1995). Infectious Disease Unit Pescara General Hospital Indeed, the detection of EBV DNA by PCR in CSF Via Fonte Romana, 8 - 65124 Pescara, Italy from HIV-infected patients with PCNSL has a E-mail: [email protected] very high diagnostic sensitivity, approximating 80 276 E. Polilli, F. Sozio, E. Mazzotta, A. Consorte, F. Di Masi, A. Agostinone, M. Tontodonati, L. Cosentino, G. Parruti to 100% in recent series (Bossolasco et al ., 2002; HHV6, HHV8, CMV, JC virus and Mycobacteria. De Luca et al ., 1995; Cinque et al ., 1996). EBV Cultures for Cryptococcus were negative. HIV vi - was undetectable in most patients without PC - ral load in the CSF was 261,000 cp/mL. EBV DNA NSL in such series. and other herpes viruses were not amplified from While the presence of EBV DNA in CSF has been parallel peripheral blood samples. related with later development of PCNSL in some A first brain magnetic resonance imaging (MRI) studies (Al-Shahi et al ., 2000; Brink et al ., 1998), scan showed an apparently normal pattern. others failed to demonstrate an increased risk of Antiviral therapy with i.v. aciclovir was soon es - developing PCNSL in patients with detectable tablished at standard doses, without benefit. EBV DNA in CSF (Tachikawa et al ., 1999; Wang Three days later, therefore, an association of i.v. et al ., 2007). ganciclovir and foscarnet was started at standard This report describes the case of an HIV-infected doses. man, who was diagnosed with HIV infection and In spite of that, the patient rapidly progressed to AIDS due to Pneumocystis jiroveci pneumonia a state of light coma, difficult to awaken. A sec - and soon after presented a rapidly progressive ond MRI brain scan with and without contrast and lethal deterioration of consciousness, which medium was again normal, without any evidence was related to a high EBV viral load in CNS, in of organic lesions, while EEG monitoring docu - the absence of any other evidence of CNS infec - mented a worsening of bioelectric patterns. tion, apart from HIV. On the tenth day HAART was started (lopinavir, The patient died 12 days after the onset of signs LPV; stavudine, d4T; lamivudine, 3TC), without of encephalitis in spite of prompt introduction of any improvement. A few days later the patient HAART and combined treatment with ganciclovir showed progressive focal neurological involve - and foscarnet. ment (strabismus and a coarse tremor), deepen - ing in his state of coma and necessitating reloca - tion at an intensive care unit. A third MRI scan CASE REPORT could not be therefore be undertaken. Thirteen days after admission, the patient died due to car - The patient, a 40-year-old heterosexual diac arrest, in spite of any attempt at resuscita - Caucasian, came to our attention for the first time tion. Autoptic examination was not granted. in February, 2008, transferred from another Institute due to worsening dyspnea not respon - sive to antibiotics. Severe pulmonary interstitial DISCUSSION disease was molecularly diagnosed by real-time PCR as Pneumocystis Jiroveci pneumonia. HIV The rapid and irreversible neurological progres - infection was documented for the first time; CD4 sion of our patient is of relevance, as it may rep - T-cell count was 56 mm 3 and HIV viral load was resent the first evidence of rapidly progressive 555,000 cp/mL. and lethal EBV-related encephalitis in an HIV pa - Treatment with i.v. cotrimoxazole was effective tient. Indeed, his fatal course occurred in the ab - in controlling fever and dyspnea, but on the third sence of any evidence of other causative agents day the patient showed rapidly worsening sleepi - of encephalitis in his CSF and in spite of combi - ness in the absence of focal neurological deficits nation antiviral therapy for EBV and HAART, and/or any sign of peripheral neuropathy. A brain whereas treatment with cotrimoxazole controlled CT scan with and without contrast medium did his presentation pneumonia. Indeed, HIV itself not reveal any obvious organic damage, while a was amplified from CSF at high titer. first EEG showed diffuse slow discharge, consis - Our patient, however, did not present any of the tent with severe encephalopathy. clinical characteristics which have been report - Routine CSF analysis was normal, with no cellu - ed for HIV-related meningo-encephalitis: he was lar sediment, and a modest increase in CSF pro - a late presenter, with very low CD4 T-cell counts teins. Real Time PCR on CSF, however, amplified in his peripheral blood, did not present any sign EBV DNA at a high titer (11,230 cp/mL), while it of meningitis, and no cellular sediment was de - was negative for pathogens such as HSV1-2, tected on CSF (Villar Del Saz et al ., 2008). Rapidly progressive and fatal EBV-related encephalitis 277 Furthermore, pneumonia due to Pneumocystis Katramados et al . reported a possible case of jiroveci was his presenting condition, followed by EBV-related encephalitis in a HIV patient treated rapid deterioration of his mental state and late with HAART and a relatively preserved immune appearance of focal neurological signs after the system (Katramados et al ., 2007). In this case, the start of HAART with a lopinavir-based regimen, patient experienced early partial clinical im - which may well have rapidly controlled HIV repli - provement and a clinical relapse of encephalitis cation in CSF (Letendre et al ., 2007). For this rea - during maintenance therapy with oral valganci - son, we felt that the diagnosis of HIV-related clovir. The authors reported a favorable course meningo-encephalitis was not likely on a clinical after restoring therapy with intravenous ganci - basis, although a concurrent role of HIV cannot clovir and suggested that restoration of immune be excluded. Serial electroencephalographic eval - control induced by HAART may have prevented uations showed patterns of severe encephalopa - development of PCNSL, thus inducing an un - thy, with progressively diffuse lateralizing epilep - usual clinical expression of persistent EBV in - tiform discharges, in the absence of any neuro - fection, that is recurrent encephalitis. Our expe - radiologic evidence of brain damage or PCNSL rience would therefore suggest for the first time on serial MRI scans. A causative role for EBV was the occurrence of EBV-related encephalitis in an therefore supported by its very high titer in CSF, advanced, severely immunosuppressed patient at as well by the absence of other known pathogens presentation of HIV infection, without any sign of such as HSV1-2, CMV, HHV-6, VZV, JC virus, lymphoma. HHV-8, Cryptococcus and Mycobacteria In spite of association therapy with i.v. gancy - (Landgren et al ., 1994; Cinque et al ., 2003). clovir and foscarnet and the early start of HAART, Interestingly, EBV was not amplified on a paral - a rapid worsening of encephalitis with progres - lel peripheral blood sample drawn at the time of sion to status epilepticus ensued. This was un - CSF sampling, adding to the causative role of its likely to be due to the emergence of viral resist - reactivation in CSF (Pedneault et al ., 1992; Volpi, ance, a well-known phenomenon with other her - 2004).
Load more

Recommended publications
  • Everything You Always Wanted to Know About Rabies Virus ♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣♣ (But Were Afraid to Ask) Benjamin M
    ANNUAL REVIEWS Further Click here to view this article's online features: t%PXOMPBEmHVSFTBT115TMJEFT t/BWJHBUFMJOLFESFGFSFODFT t%PXOMPBEDJUBUJPOT Everything You Always Wanted t&YQMPSFSFMBUFEBSUJDMFT t4FBSDILFZXPSET to Know About Rabies Virus (But Were Afraid to Ask) Benjamin M. Davis,1 Glenn F. Rall,2 and Matthias J. Schnell1,2,3 1Department of Microbiology and Immunology and 3Jefferson Vaccine Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, 19107; email: [email protected] 2Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 Annu. Rev. Virol. 2015. 2:451–71 Keywords First published online as a Review in Advance on rabies virus, lyssaviruses, neurotropic virus, neuroinvasive virus, viral June 24, 2015 transport The Annual Review of Virology is online at virology.annualreviews.org Abstract This article’s doi: The cultural impact of rabies, the fatal neurological disease caused by in- 10.1146/annurev-virology-100114-055157 fection with rabies virus, registers throughout recorded history. Although Copyright c 2015 by Annual Reviews. ⃝ rabies has been the subject of large-scale public health interventions, chiefly All rights reserved through vaccination efforts, the disease continues to take the lives of about 40,000–70,000 people per year, roughly 40% of whom are children. Most of Access provided by Thomas Jefferson University on 11/13/15. For personal use only. Annual Review of Virology 2015.2:451-471. Downloaded from www.annualreviews.org these deaths occur in resource-poor countries, where lack of infrastructure prevents timely reporting and postexposure prophylaxis and the ubiquity of domestic and wild animal hosts makes eradication unlikely. Moreover, al- though the disease is rarer than other human infections such as influenza, the prognosis following a bite from a rabid animal is poor: There is cur- rently no effective treatment that will save the life of a symptomatic rabies patient.
    [Show full text]
  • Progressive Multifocal Leukoencephalopathy and the Spectrum of JC Virus-​Related Disease
    REVIEWS Progressive multifocal leukoencephalopathy and the spectrum of JC virus- related disease Irene Cortese 1 ✉ , Daniel S. Reich 2 and Avindra Nath3 Abstract | Progressive multifocal leukoencephalopathy (PML) is a devastating CNS infection caused by JC virus (JCV), a polyomavirus that commonly establishes persistent, asymptomatic infection in the general population. Emerging evidence that PML can be ameliorated with novel immunotherapeutic approaches calls for reassessment of PML pathophysiology and clinical course. PML results from JCV reactivation in the setting of impaired cellular immunity, and no antiviral therapies are available, so survival depends on reversal of the underlying immunosuppression. Antiretroviral therapies greatly reduce the risk of HIV-related PML, but many modern treatments for cancers, organ transplantation and chronic inflammatory disease cause immunosuppression that can be difficult to reverse. These treatments — most notably natalizumab for multiple sclerosis — have led to a surge of iatrogenic PML. The spectrum of presentations of JCV- related disease has evolved over time and may challenge current diagnostic criteria. Immunotherapeutic interventions, such as use of checkpoint inhibitors and adoptive T cell transfer, have shown promise but caution is needed in the management of immune reconstitution inflammatory syndrome, an exuberant immune response that can contribute to morbidity and death. Many people who survive PML are left with neurological sequelae and some with persistent, low-level viral replication in the CNS. As the number of people who survive PML increases, this lack of viral clearance could create challenges in the subsequent management of some underlying diseases. Progressive multifocal leukoencephalopathy (PML) is for multiple sclerosis. Taken together, HIV, lymphopro- a rare, debilitating and often fatal disease of the CNS liferative disease and multiple sclerosis account for the caused by JC virus (JCV).
    [Show full text]
  • Congenital Cytomegalovirus Infection Alters Olfaction Before Hearing Deterioration in Mice
    10424 • The Journal of Neuroscience, December 5, 2018 • 38(49):10424–10437 Development/Plasticity/Repair Congenital Cytomegalovirus Infection Alters Olfaction Before Hearing Deterioration In Mice X Franc¸oise Lazarini,1,2 Lida Katsimpardi,1,2* Sarah Levivien,1,2,3*Se´bastien Wagner,1,2 XPierre Gressens,3,4,5 Natacha Teissier,3,4,6† and Pierre-Marie Lledo1,2† 1Institut Pasteur, Perception and Memory Unit, F-75015 Paris, France, 2Centre National de la Recherche Scientifique, Unite´ Mixte de Recherche 3571, F-75015 Paris, France, 3PROTECT, INSERM, Unite´ 1141, F-75019 Paris, France, 4Paris Diderot University, Sorbonne Paris Cite´, F-75018 Paris, France, 5Center for Developing Brain, King’s College, London, WC2R2LS United Kingdom, and 6Pediatric Otorhinolaryngology Department, Robert Debre´ Hospital, Assistance Publique–Hoˆpitaux de Paris, F-75019 Paris, France In developed countries, cytomegalovirus (CMV)-infected newborns are at high risk of developing sensorineural handicaps such as hearing loss, requiring extensive follow-up. However, early prognostic tools for auditory damage in children are not yet available. In the fetus, CMV infection leads to early olfactory bulb (OB) damage, suggesting that olfaction might represent a valuable prognosis for neurological outcome of this viral infection. Here, we demonstrate that in utero CMV inoculation causes fetal infection and growth retardation in mice of both sexes. It disrupts OB normal development, leading to disproportionate OB cell layers and rapid major olfactory deficits. Olfaction is impaired as early as day 6 after birth in both sexes, long before the emergence of auditory deficits. Olfactometry in males reveals a long-lasting alteration in olfactory perception and discrimination, particularly in binary mixtures of monomolecular odorants.
    [Show full text]
  • The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System
    International Journal of Molecular Sciences Review The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System Raquel Bello-Morales 1,2,* , Sabina Andreu 1,2 and José Antonio López-Guerrero 1,2 1 Departamento de Biología Molecular, Universidad Autónoma de Madrid, Cantoblanco, 28049 Madrid, Spain; [email protected] (S.A.); [email protected] (J.A.L.-G.) 2 Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Cantoblanco, 28049 Madrid, Spain * Correspondence: [email protected] Received: 30 June 2020; Accepted: 15 July 2020; Published: 16 July 2020 Abstract: Herpes simplex type 1 (HSV-1) is a neurotropic virus that infects the peripheral and central nervous systems. After primary infection in epithelial cells, HSV-1 spreads retrogradely to the peripheral nervous system (PNS), where it establishes a latent infection in the trigeminal ganglia (TG). The virus can reactivate from the latent state, traveling anterogradely along the axon and replicating in the local surrounding tissue. Occasionally, HSV-1 may spread trans-synaptically from the TG to the brainstem, from where it may disseminate to higher areas of the central nervous system (CNS). It is not completely understood how HSV-1 reaches the CNS, although the most accepted idea is retrograde transport through the trigeminal or olfactory tracts. Once in the CNS, HSV-1 may induce demyelination, either as a direct trigger or as a risk factor, modulating processes such as remyelination, regulation of endogenous retroviruses, or molecular mimicry. In this review, we describe the current knowledge about the involvement of HSV-1 in demyelination, describing the pathways used by this herpesvirus to spread throughout the CNS and discussing the data that suggest its implication in demyelinating processes.
    [Show full text]
  • Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis
    ARTICLE OPEN ACCESS Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis Philipp Schwenkenbecher, MD, Thomas Skripuletz, MD, Peter Lange, Marc Durr,¨ MD, Felix F. Konen, MD, Correspondence Nora Mohn,¨ MD, Marius Ringelstein, MD, Til Menge, MD, Manuel A. Friese, MD, Nico Melzer, MD, Dr. Schwenkenbecher schwenkenbecher.philipp@ ¨ Michael P. Malter, MD, Martin Hausler, MD, Franziska S. Thaler, MD, Martin Stangel, MD, Jan Lewerenz, MD, mh-hannover.de and Kurt-Wolfram Suhs,¨ MD, on behalf of the German Network for Research on Autoimmune Encephalitis Neurol Neuroimmunol Neuroinflamm 2021;8:e1062. doi:10.1212/NXI.0000000000001062 Abstract Background and Objectives Neurotropic viruses are suspected to play a role in the pathogenesis of autoimmune diseases of the CNS such as the association between the Epstein-Barr virus (EBV) and multiple sclerosis (MS). A group of autoimmune encephalitis (AE) is linked to antibodies against neuronal cell surface proteins. Because CNS infection with the herpes simplex virus can trigger anti–NMDA receptor (NMDAR) encephalitis, a similar mechanism for EBV and other neurotropic viruses could be postulated. To investigate for previous viral infections of the CNS, intrathecally produced virus-specific antibody synthesis was determined in patients with AE. Methods Antibody-specific indices (AIs) against EBV and measles, rubella, varicella zoster, herpes simplex virus, and cytomegalovirus were determined in 27 patients having AE (anti-NMDAR encephalitis, n = 21, and LGI1 encephalitis, n = 6) and in 2 control groups comprising of 30 patients with MS and 21 patients with noninflammatory CNS diseases (NIND), which were sex and age matched. Results An intrathecal synthesis of antibodies against EBV was found in 5/27 (19%) patients with AE and 2/30 (7%) of the patients with MS.
    [Show full text]
  • Neurotropic Viral Infections in Bangladesh: Burden and Challenges
    http://www.banglajol.info/index.php/BJID/index Editorial Bangladesh Journal of Infectious Diseases June 2016, Volume 3, Number 1 ISSN (Online) 2411-670X ISSN (Print) 2411-4820 Neurotropic Viral Infections in Bangladesh: Burden and Challenges Mohammad Enayet Hussain Assistant Professor, Department of Neurology, National Institute of Neurosciences & Hospital, Dhaka, Bangladesh; Email: [email protected] Neurotropic virus infections continue to cause encephalopathies. In addition, influenza viruses major disease and economic burdens on society1. It have been linked to the development of Guillan poses a major challenge to human health care Barré syndrome, Kleine Levin syndrome and systems due to the associated morbidity and transfer myelitis5. Maternal influenza has been mortality worldwide. This creates a unique problem associated with schizophrenia and bipolar disorder in providing treatment to the patients involved. This (BD) in the offspring. Acute demyelinating is largely due to unique features of the central encephalomyelitis (ADME) typically occurs in nervous system (CNS), with a plethora of measles patients. Subacute sclerosing interconnected and interdependent cell types, panencephalitis (SSPE) occurs on average 4– complex structures and functions, reduced immune 10 years following acute MV infection. Mumps surveillance and limited regeneration capacity. virus was the leading cause of aseptic meningitis in Infection by neurotropic viruses as well as the local the pre-vaccine era. Pathologically, mumps induced immune responses can
    [Show full text]
  • Cns Response in a Rabid Brain: a Pathological View
    Review Article ISSN 2250-0480 VOL 5/ ISSUE 4/OCT 2015 CNS RESPONSE IN A RABID BRAIN: A PATHOLOGICAL VIEW 1PREETY SHARMA, 1 SANJEEV KUMAR,2 V. K. SHARMA* & AJAY KUMAR TEHLAN 1Central Research Institute, Kasauli, District Solan, Himachal Pradesh -173204, India. 2Department of Pharmacology, Govt. College of Pharmacy, Rohru, Distt. Shimla, Himachal Pradesh-171207, India ABSTRACT Animal attacks constitute a huge medical and social problem ending in millions of injuries and thousands of deaths worldwide. Rabies is a dreadful infectious disease that has not been brought under control in many parts of the world even today. Rabies spread by domestic and wild animals particularly by a dog bite, and with the exception of Antarctica, rabies is present on all continents, taking a heavy toll on human lives. Many countries have the status of high-risk areas, but most of the countries around the globe gained the status of rabies free territories. This shows that rabies can be successfully ruled out from the high-risk areas by taking preventing measures and the situation may be better if we continue to untangle the mysterious pathophysiology of this disease. Understanding rabies invasion and its pathophysiology will further enhance the chances of improvement rabies related complications and mortality. Rabies is a prototypic infection of the nervous system in which the virus selectively infects neurons, using retrograde axonal transport to traffic in the nervous system. Neuroinvasiveness, neurotropism and neurovirulence are the major defining characteristics of this virus. The speed of virus uptake, the ability of the virus to spread efficiently from cell-to-cell and the rate of virus replication are the major factors that determine the pathogenicity of rabies virus.
    [Show full text]
  • คาศัพท์เฉพาะทางด้านการแพทย์ในหมวด Neurotropic Virus
    รายงาน ค าศัพท์เฉพาะทางด้านการแพทย์ในหมวด Neurotropic virus Virus ที่มีผลต่อ Cell neuron จัดท าโดย 1. นสพ. กฤตภาส กิจสนาโยธิน รหัสนิสิต 58460042 2. นสพ. จารุกิตติ์ อุบลสะอาด รหัสนิสิต 58460127 3. นสพ. ชนิกานต์ เดชขุนทด รหัสนิสิต 58460189 4. นสพ. พงศ์ศิริ บัวนุ่ม รหัสนิสิต 58460431 5. นสพ. พิมพ์ประไพ ศิลากุล รหัสนิสิต 58460516 6. นสพ. เพ็ญพิชญา มาราช รหัสนิสิต 58460547 7. นสพ. ภัทราวดี เดือนเพ็ญ รหัสนิสิต 58460585 8. นสพ. ภูดิศญา ตั้งวรสิทธิชัย รหัสนิสิต 58460608 9. นสพ. สุชาดา วิเศษกุลพรหม รหัสนิสิต 58460820 10. นสพ. ธนกฤต อนันตจันทรา รหัสนิสิต 58461025 นิสิตแพทย์ชั้นปีที่ 2 กลุ่มที่ 2 เสนอ ผู้ช่วยศาสตราจารย์ นายแพทย์ ดร. ณตพล ศุภณัฐเศรษฐกุล รายงานนี้เป็นส่วนหนึ่งของวิชา 499721 ค าศัพท์เฉพาะทางด้านการแพทย์ คณะแพทยศาสตร์ มหาวิทยาลัยนเรศวร ภาคเรียนที่ 1 ปีการศึกษา 2559 ก ค ำน ำ รายงานฉบับนี้เป็นส่วนหนึ่งของรายวิชาค าศัพท์เฉพาะทางด้านการแพทย์ 499721 โดยมี จุดประสงค์ เพื่อศึกษาค าศัพท์เฉพาะทางการแพทย์ในหมวดขอกลุ่ม Neurotropic virus Virus ที่ มีผลต่อ Cell neuron ซึ่งรายงานนี้มีเนื้อหาเกี่ยวกับไวรัสชนิดต่างๆที่มีผลต่อ cell neuron จ านวน 10 ชนิด โดยศึกษาถึงวิธีการออกเสียง ชนิดของค าศัพท์ ที่มาของค าศัพท์ ความหมายของ ค าศัพท์และศัพท์บัญญัติในภาษาไทย นอกจากนั้นยังมีรายละเอียดเพิ่มเติมเกี่ยวกับไวรัสชนิดนั้นๆ รวมถึงรูปภาพประกอบเพื่อเสริมความเข้าใจอีกด้วย ผู้จัดท าได้เลือกหัวข้อนี้ในการท ารายงาน เนื่องมาจากเป็นเรื่องที่น่าสนใจ รวมถึงเป็นเรื่องที่ ค่อนข้างแปลกใหม่ ผู้จัดท าจะต้องขอขอบคุณ ผู้ช่วยศาสตราจารย์ นายแพทย์ ดร. ณตพล ศุภณัฐเศรษฐกุล ผู้ให้ความรู้ และแนวทางการศึกษารวมถึง อ.พญ.สาธิณี ชูเชิด อาจารย์ผู้ช่วยใน รายวิชานี้ที่คอยให้ค าแนะน าในเรื่องต่าง
    [Show full text]
  • Rabies and Importance Rabies Is a Viral Disease That Affects the Central Nervous System (CNS) of Mammals Rabies-Related and Has an Extremely High Case Fatality Rate
    Rabies and Importance Rabies is a viral disease that affects the central nervous system (CNS) of mammals Rabies-Related and has an extremely high case fatality rate. Once clinical signs develop, there are very few survivors. Vaccines can protect pets, as well as people exposed to these animals, Lyssaviruses but the maintenance of rabies viruses in wildlife complicates control. In humans, illness can be prevented by administering anti-rabies antibodies and a series of vaccinations, Hydrophobia, provided exposure is recognized before the symptoms appear. However, people in Lyssa impoverished countries do not always have access to effective post-exposure prophylaxis. Due to this and other factors, such as inadequate levels of vaccination in dogs and cats, the annual incidence of human rabies is estimated to be 40,000 or more Last Updated: November 2012 cases, worldwide. A few cases occur even in nations with good medical care, typically in people who did not realize they were exposed. Closely related lyssaviruses circulate among bats in the Eastern Hemisphere, and can cause an illness identical to rabies in people and domesticated animals. Rabies vaccines and post-exposure prophylaxis are thought to provide some protection against some of these viruses, but not others. Rabies-related lyssaviruses can be found even in countries classified as rabies-free. Etiology Rabies is caused by the rabies virus, a neurotropic virus in the genus Lyssavirus, family Rhabdoviridae. There are many variants (or strains) of this virus, each maintained in a particular reservoir host. The reservoir host may be reflected in the case description. For example, if a virus maintained in skunks caused rabies in a dog, it would be described as skunk rabies in a dog, rather than canine rabies.
    [Show full text]
  • Neurotropic Viruses, Astrocytes, and COVID-19
    fncel-15-662578 April 3, 2021 Time: 12:32 # 1 REVIEW published: 09 April 2021 doi: 10.3389/fncel.2021.662578 Neurotropic Viruses, Astrocytes, and COVID-19 Petra Tavcarˇ 1, Maja Potokar1,2, Marko Kolenc3, Miša Korva3, Tatjana Avšic-Župancˇ 3, Robert Zorec1,2* and Jernej Jorgacevskiˇ 1,2 1 Laboratory of Neuroendocrinology–Molecular Cell Physiology, Institute of Pathophysiology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, 2 Celica Biomedical, Ljubljana, Slovenia, 3 Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia At the end of 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) was discovered in China, causing a new coronavirus disease, termed COVID-19 by the WHO on February 11, 2020. At the time of this paper (January 31, 2021), more than 100 million cases have been recorded, which have claimed over 2 million lives worldwide. The most important clinical presentation of COVID-19 is severe pneumonia; however, many patients present various neurological symptoms, ranging from loss of olfaction, nausea, dizziness, and headache to encephalopathy and stroke, with a high prevalence of inflammatory central nervous system (CNS) syndromes. SARS-CoV-2 may Edited by: also target the respiratory center in the brainstem and cause silent hypoxemia. However, Alexei Verkhratsky, the neurotropic mechanism(s) by which SARS-CoV-2 affects the CNS remain(s) unclear. The University of Manchester, United Kingdom In this paper, we first address the involvement of astrocytes in COVID-19 and then Reviewed by: elucidate the present knowledge on SARS-CoV-2 as a neurotropic virus as well as Arthur Morgan Butt, several other neurotropic flaviviruses (with a particular emphasis on the West Nile virus, University of Portsmouth, tick-borne encephalitis virus, and Zika virus) to highlight the neurotropic mechanisms United Kingdom Alexey Semyanov, that target astroglial cells in the CNS.
    [Show full text]
  • Is Human Cytomegalovirus a Target in Cancer Therapy?
    www.impactjournals.com/oncotarget/ Oncotarget, December, Vol.2, No 12 Is human cytomegalovirus a target in cancer therapy? John Inge Johnsen1, Ninib Baryawno1 and Cecilia Söderberg-Nauclér2 1 Childhood Cancer Research Unit, Department of Women´s and Children´s Health, Karolinska Institute, 171 76 Stockholm, Sweden 2 Karolinska Institute, Department of Medicine, Center for Molecular Medicine, Karolinska University Hospital in Solna, 171 76 Stockholm, Sweden Correspondence to: John Inge Johnsen, email: [email protected] Keywords: cancer, human cytomegalovirus Received: December 12, 2011, Accepted: December 15, 2011, Published: December 31, 2011 Copyright: © Johnsen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT: Human cytomegalovirus (HCMV) is a herpesvirus that is prevalent in the human population. HCMV has recently been implicated in different cancer forms where it may provide mechanisms for oncogenic transformation, oncomodulation and tumour cell immune evasion. Moreover, antiviral treatment against HCMV has been shown to inhibit tumour growth in preclinical models. Here we describe the possible involvement of HCMV in cancer and discuss the potential molecular impact expression of HCMV proteins have on tumour cells and the surrounding tumour microenvironment. INTRODUCTION characteristic crucial for the tumour cell to sustain a proliferative
    [Show full text]
  • New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy
    Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2013, Article ID 839719, 17 pages http://dx.doi.org/10.1155/2013/839719 Review Article New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy Anna Bellizzi,1 Elena Anzivino,1 Donatella Maria Rodio,1 Anna Teresa Palamara,2,3 Lucia Nencioni,2 and Valeria Pietropaolo1,4 1 Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, P.le Aldo Moro, 5-00185 Rome, Italy 2 Department of Public Health and Infectious Diseases, Institute Pasteur, Cenci-Bolognetti Foundation, “Sapienza” University of Rome, P.le Aldo Moro, 5-00185 Rome, Italy 3 San Raffaele Pisana Scientific Institute for Research, Hospitalization and Health Care, Via Val Cannuta, 247-00166 Rome, Italy 4 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology , Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA Correspondence should be addressed to Valeria Pietropaolo; [email protected] Received 7 January 2013; Accepted 6 March 2013 Academic Editor: Serena Delbue Copyright © 2013 Anna Bellizzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. John Cunningham virus (JCV) is a member of the Polyomaviridae family. It was first isolated from the brain of a patient with Hodgkin disease in 1971, and since then the etiological agent of the progressive multifocal leukoencephalopathy (PML) was considered. Until the human immunodeficiency virus (HIV) pandemic, PML was rare: in fact HIV-induced immunodeficiency is the most common predisposing factor accounting for 85% of all instances of PML.
    [Show full text]